Redmile Group, LLC Neoleukin Therapeutics, Inc. Transaction History

Redmile Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.68 - $0.91 $723,947 - $968,811	1,064,628 Added 57.62%	2,912,228 $2.42 Million
Q1 2023 May 15, 2023	SELL	$0.5 - $0.72 $1,483 - $2,135	-2,966 Reduced 0.16%	1,847,600 $1.29 Million
Q4 2022 Feb 14, 2023	SELL	$0.4 - $0.55 $634,547 - $872,502	-1,586,369 Reduced 46.16%	1,850,566 $943,000
Q2 2022 Aug 15, 2022	SELL	$0.92 - $2.25 $26,220 - $64,125	-28,500 Reduced 0.82%	3,436,935 $3.54 Million
Q1 2022 May 16, 2022	SELL	$1.72 - $5.23 $43,688 - $132,842	-25,400 Reduced 0.73%	3,465,435 $6.52 Million
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.75 $76,260 - $127,100	-16,400 Reduced 0.47%	3,490,835 $16.8 Million
Q3 2021 Nov 15, 2021	SELL	$6.05 - $9.66 $2.49 Million - $3.98 Million	-412,000 Reduced 10.51%	3,507,235 $25.4 Million
Q2 2021 Aug 16, 2021	SELL	$9.23 - $13.12 $1.83 Million - $2.6 Million	-198,334 Reduced 4.82%	3,919,235 $36.2 Million
Q1 2021 May 17, 2021	SELL	$11.26 - $15.78 $161,018 - $225,654	-14,300 Reduced 0.35%	4,117,569 $50.7 Million
Q4 2020 Feb 16, 2021	SELL	$10.17 - $14.56 $415,108 - $594,295	-40,817 Reduced 0.98%	4,131,869 $58.3 Million
Q3 2020 Nov 16, 2020	BUY	$9.68 - $17.01 $1.27 Million - $2.24 Million	131,475 Added 3.25%	4,172,686 $50.1 Million
Q1 2020 May 15, 2020	BUY	$6.12 - $13.64 $13 Million - $28.9 Million	2,120,380 Added 110.39%	4,041,211 $46 Million
Q4 2019 Feb 14, 2020	BUY	$2.65 - $12.72 $5.09 Million - $24.4 Million	1,920,831 New	1,920,831 $23.7 Million

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.